Neurobiological Technologies, Inc.
NTII
$0.00
$0.000.00%
OTC PK
| 12/17/2009 | 09/30/2009 | 06/30/2009 | 03/31/2009 | 12/31/2008 | |
|---|---|---|---|---|---|
| Revenue | -- | 69.03% | 363.45% | -18.21% | -4.70% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 69.03% | 363.45% | -18.21% | -4.70% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | 69.03% | 363.45% | -18.21% | -4.70% |
| SG&A Expenses | -44.80% | -34.03% | -28.21% | -29.54% | -37.19% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -94.28% | -87.06% | -86.38% | -65.01% | 24.28% |
| Operating Income | 91.82% | 259.98% | 502.79% | 107.91% | -43.02% |
| Income Before Tax | 93.56% | 299.17% | 509.79% | 91.49% | -13.87% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 94.11% | 295.69% | 509.79% | 91.49% | -13.87% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 94.11% | 295.69% | 509.79% | 91.49% | -13.87% |
| EBIT | 91.82% | 259.98% | 502.79% | 107.91% | -43.02% |
| EBITDA | 91.83% | 262.89% | 508.81% | 108.60% | -43.55% |
| EPS Basic | 94.13% | 295.61% | 513.09% | 91.49% | 18.32% |
| Normalized Basic EPS | 92.08% | 287.67% | 547.13% | 106.82% | 18.32% |
| EPS Diluted | 93.13% | 294.93% | 512.45% | 91.49% | 18.32% |
| Normalized Diluted EPS | 92.08% | 287.52% | 547.13% | 106.82% | 18.32% |
| Average Basic Shares Outstanding | 0.22% | 0.02% | -0.77% | 0.05% | 39.41% |
| Average Diluted Shares Outstanding | 0.22% | 0.08% | -0.77% | 0.05% | 39.41% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |